LT2244722T - Mikrobinių infekcijų gydymas - Google Patents
Mikrobinių infekcijų gydymasInfo
- Publication number
- LT2244722T LT2244722T LTEP09705327.6T LT09705327T LT2244722T LT 2244722 T LT2244722 T LT 2244722T LT 09705327 T LT09705327 T LT 09705327T LT 2244722 T LT2244722 T LT 2244722T
- Authority
- LT
- Lithuania
- Prior art keywords
- treatment
- microbial infections
- infections
- microbial
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000000813 microbial effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE20080070 | 2008-01-31 | ||
GBGB0801768.3A GB0801768D0 (en) | 2008-01-31 | 2008-01-31 | Treatment of microbial infections |
PCT/EP2009/051033 WO2009095453A1 (en) | 2008-01-31 | 2009-01-29 | Treatment of microbial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
LT2244722T true LT2244722T (lt) | 2016-10-25 |
Family
ID=40512496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LTEP09705327.6T LT2244722T (lt) | 2008-01-31 | 2009-01-29 | Mikrobinių infekcijų gydymas |
Country Status (22)
Country | Link |
---|---|
US (3) | US20110150918A1 (lt) |
EP (2) | EP3117832B1 (lt) |
JP (1) | JP5709527B2 (lt) |
KR (1) | KR101739048B1 (lt) |
CN (1) | CN101983067B (lt) |
AU (1) | AU2009209598B2 (lt) |
BR (1) | BRPI0906997A2 (lt) |
CA (1) | CA2713241C (lt) |
CY (1) | CY1118153T1 (lt) |
DK (1) | DK2244722T3 (lt) |
EA (1) | EA019516B1 (lt) |
ES (2) | ES2599953T3 (lt) |
HR (1) | HRP20161305T1 (lt) |
HU (1) | HUE031614T2 (lt) |
LT (1) | LT2244722T (lt) |
MX (1) | MX2010008423A (lt) |
PL (1) | PL2244722T3 (lt) |
PT (1) | PT2244722T (lt) |
SG (1) | SG188102A1 (lt) |
SI (1) | SI2244722T1 (lt) |
WO (1) | WO2009095453A1 (lt) |
ZA (1) | ZA201005798B (lt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1996231A4 (en) * | 2006-02-22 | 2010-09-15 | Texas A & M Univ Sys | ANTIBODIES RECOGNIZING A HIGHLY EXPRESS PUTATIVE ANTIGEN OF SARM-C AND METHODS OF USE |
DK2244722T3 (en) | 2008-01-31 | 2016-11-14 | The Provost Fellows Found Scholars & The Other Members Of Board Of The College Of The Holy & Undiv T | Treating microbial infections |
AR078601A1 (es) | 2009-06-22 | 2011-11-23 | Wyeth Llc | Composiciones inmunogenicas de antigenos de staphylococcus aureus |
EP2454284B1 (en) | 2009-07-15 | 2018-04-11 | AIMM Therapeutics B.V. | Gram-positive bacteria specific binding compounds |
ES2625979T3 (es) | 2009-07-16 | 2017-07-21 | Glaxosmithkline Biologicals S.A. | Tratamiento de infecciones |
GB0913680D0 (en) * | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
WO2011045573A2 (en) * | 2009-10-15 | 2011-04-21 | University Court Of The University Of Edinburgh | Staphylococcal antigens |
CN101843899B (zh) * | 2010-05-24 | 2012-11-07 | 中国人民解放军第三军医大学 | 耐甲氧西林金黄色葡萄球菌(mrsa)重组多亚单位基因工程疫苗及其制备方法 |
US9095540B2 (en) | 2010-09-09 | 2015-08-04 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens |
WO2013159021A1 (en) * | 2012-04-20 | 2013-10-24 | The Texas A&M University System | Engineered collagen binding mscramm with enhanced affinity for collagen |
RU2698131C2 (ru) * | 2012-11-06 | 2019-08-22 | МЕДИММЬЮН, ЭлЭлСи | Антитела к поверхностным детерминантам s. aureus |
GB201310008D0 (en) | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
WO2016091904A1 (en) | 2014-12-10 | 2016-06-16 | Glaxosmithkline Biologicals Sa | Method of treatment |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
US10738338B2 (en) | 2016-10-18 | 2020-08-11 | The Research Foundation for the State University | Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate |
GB201802339D0 (en) * | 2018-02-13 | 2018-03-28 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
ES2832881T3 (es) * | 2018-04-24 | 2021-06-11 | Fibriant B V | Variantes de fibrinógeno gamma prima para su uso en el tratamiento de una infección |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008341A (en) * | 1994-08-22 | 1999-12-28 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin | S. aureus fibrinogen binding protein gene |
AU4810600A (en) * | 1999-04-28 | 2000-11-10 | Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin, The | Method of inhibiting leukocyte adhesion to fibrinogen |
CA2351018A1 (en) * | 2001-07-09 | 2003-01-09 | Universite De Sherbrooke | Dna vaccine against staphylococcus aureus |
US7771731B2 (en) | 2004-05-21 | 2010-08-10 | Wyeth Llc | Altered fibronectin-binding protein of Staphylococcus aureus |
DK2244722T3 (en) | 2008-01-31 | 2016-11-14 | The Provost Fellows Found Scholars & The Other Members Of Board Of The College Of The Holy & Undiv T | Treating microbial infections |
-
2009
- 2009-01-29 DK DK09705327.6T patent/DK2244722T3/en active
- 2009-01-29 KR KR1020107019237A patent/KR101739048B1/ko active IP Right Grant
- 2009-01-29 EA EA201001212A patent/EA019516B1/ru not_active IP Right Cessation
- 2009-01-29 ES ES09705327.6T patent/ES2599953T3/es active Active
- 2009-01-29 SI SI200931536A patent/SI2244722T1/sl unknown
- 2009-01-29 EP EP16173940.4A patent/EP3117832B1/en active Active
- 2009-01-29 WO PCT/EP2009/051033 patent/WO2009095453A1/en active Application Filing
- 2009-01-29 LT LTEP09705327.6T patent/LT2244722T/lt unknown
- 2009-01-29 CA CA2713241A patent/CA2713241C/en active Active
- 2009-01-29 BR BRPI0906997-6A patent/BRPI0906997A2/pt not_active Application Discontinuation
- 2009-01-29 US US12/865,336 patent/US20110150918A1/en not_active Abandoned
- 2009-01-29 MX MX2010008423A patent/MX2010008423A/es active IP Right Grant
- 2009-01-29 HU HUE09705327A patent/HUE031614T2/en unknown
- 2009-01-29 PT PT97053276T patent/PT2244722T/pt unknown
- 2009-01-29 ES ES16173940T patent/ES2960604T3/es active Active
- 2009-01-29 JP JP2010544703A patent/JP5709527B2/ja active Active
- 2009-01-29 AU AU2009209598A patent/AU2009209598B2/en not_active Ceased
- 2009-01-29 SG SG2013007786A patent/SG188102A1/en unknown
- 2009-01-29 EP EP09705327.6A patent/EP2244722B1/en not_active Revoked
- 2009-01-29 PL PL09705327T patent/PL2244722T3/pl unknown
- 2009-01-29 CN CN200980112527.0A patent/CN101983067B/zh active Active
-
2010
- 2010-08-13 ZA ZA2010/05798A patent/ZA201005798B/en unknown
-
2015
- 2015-05-01 US US14/701,789 patent/US9637525B2/en active Active
-
2016
- 2016-10-10 HR HRP20161305TT patent/HRP20161305T1/hr unknown
- 2016-10-26 CY CY20161101085T patent/CY1118153T1/el unknown
-
2017
- 2017-03-20 US US15/463,665 patent/US11512118B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201005798B (en) | Treatment of microbial infections | |
EP2273989A4 (en) | POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
EP2408753A4 (en) | COMPOUNDS AND METHOD FOR THE TREATMENT OF MICROBIAL STOMACH DARM INFECTIONS IN MAMMALS | |
EP2490530A4 (en) | COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
IL208354A0 (en) | Methods of treatment | |
PL2326287T3 (pl) | Modułowe urządzenie rozprzestrzeniające do leczenia protetycznych zakażeń stawów | |
GB0818074D0 (en) | Treatment of biofilms | |
PL2696890T3 (pl) | Leczenie infekcji drobnoustrojowych | |
EP2257569A4 (en) | METHOD OF TREATMENT USING ANTIMICROBIAL COMPOSITION | |
GB0513096D0 (en) | Treatment of microbial infections | |
DK2473482T3 (en) | Methods of treating orthomyxoviral infections | |
ZA201100616B (en) | Treatment of antibiotic-resistant bacteria infection | |
EP2432479A4 (en) | OXYGEN GENERATION COMPOSITION WITH ADVANCED EFFECT FOR THE TREATMENT OF MICROBIAL INFECTIONS | |
PL2424559T3 (pl) | Sposoby leczenia zakażeń bakteryjnych z zastosowaniem orytawancyny | |
HK1139132A1 (en) | Pneumonia treatment | |
EP2417258A4 (en) | BACTERIOPHAGE COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS | |
GB0723100D0 (en) | Treatment of HFnEF | |
EP2271328A4 (en) | ANTISEPTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS | |
EP2164494A4 (en) | Methods of Treatment | |
ZA201204249B (en) | Treatment of microbial infections | |
EP2403507A4 (en) | TREATMENT OF INFECTIONS | |
ZA201100468B (en) | The treatment of helminthic infections | |
GB0801768D0 (en) | Treatment of microbial infections | |
GB0807781D0 (en) | Treatment of bacterial infection | |
GB0711704D0 (en) | Treatment of staphylococcal infections |